| No headlines available for SBHIX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
2.44M |
| Category: |
Specialty-Health |
| Total Expense Ratio: |
2.13% |
|
| PERFORMANCE & RISK | 31-Dec-07
| YTD Return: |
6.43% |
| 5y Avg Return: |
N/A |
| Rank in Category (ytd): |
150 |
| % Rank in Category (ytd): |
74.63% |
| Beta (3y): |
0.66 |
| Morningstar Risk Rating: |
Average |
|
| The investment seeks long-term growth of capital. The fund invests at least 80% of total assets in equity securities issued by healthcare companies and biotechnology companies and up to 25% of total assets in foreign companies. The fund also invests primarily in common stocks regardless of their market capitalization. This fund is nondiversified. |
|
| Fund Profile |
|
Help
0.10 (0.64%) 
Summary
Add SBHIX to Portfolio 
Download Data
